Clinical Trials Directory

Trials / Completed

CompletedNCT07134868

Sepsis and Thiol-Disulfide Balance in Emergency Department

The Diagnostic Efficacy of Thiol-Disulfide Homeostasis in Sepsis Patients

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
100 (actual)
Sponsor
Sakarya University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The aim of this study was to determine the effectiveness of thiol-disulfide homeostasis in predicting diagnosis and mortality in sepsis patients, and to compare it with other inflammatory markers.

Detailed description

Sepsis is a serious illness with high mortality rates triggered by infection-associated pathogenesis involving oxidative stress dysfunction. This study aims to elucidate the diagnostic efficacy of changes in thiol-disulfide homeostasis, its predictive role in mortality, relationship with other inflammatory parameters in sepsis patients in emergency department. In prospective, randomized controlled study, 50 patients diagnosed with sepsis according to the Sepsis-3 guidelines who presented emergency department were compared with a control group of 50 healthy volunteers. Thiol-disulfide homeostasis parameters, including total thiol, native thiol, disulfide levels, reduced thiol, oxidized thiol, and thiol oxidation-reduction ratios, were examined. Additionally, inflammatory blood parameters (C-reactive protein, procalcitonin, lactate) and mortality durations were compared with thiol-disulfide homeostasis. The objective of this study was to examine the effectiveness of thiol-disulfide homeostasis in forecasting diagnosis and mortality in sepsis patients, and to compare it against other inflammatory markers.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTThiol- Disulfide Blood Sample MeasurementMeasurement of thiol-disulfide homeostasis parameters and inflammatory markers from serum samples.

Timeline

Start date
2018-06-15
Primary completion
2018-09-30
Completion
2018-12-15
First posted
2025-08-21
Last updated
2025-08-21

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT07134868. Inclusion in this directory is not an endorsement.